Sequential PD-1 inhibitors as consolidative therapy post-CD19 CART in relapsed/refractory NHL: a propensity score matching cohort study.

J Transl Med · 2025 · PMC12595674 · PMID 41204365

Europe PMC DOI

hedged sentence

0.3660

closest p · 7.3× alpha

0.3660

boldest claim

The sentences

did not reach statistical significanceP = 0.366not close (p > 0.1)

Although the overall log-rank test for heterogeneity among subgroups did not reach statistical significance (PFS P = 0.366, OS P = 0.073, Fig. 4 A-B), likely reflecting limited power for this analysis, a clinically meaningful trend was evident.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.